Trials / Unknown
UnknownNCT04449653
Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Progentec Diagnostics, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
OASIS: A mobile study to measure and predict lupus (SLE) disease activity using digital signals The OASIS study is exploring how patient reported data and digital biomarkers, like activity level and heart rate variability, can be used to predict changes in lupus disease activity. You may receive a Withings Steel HR smartwatch as part of this study. The purpose of this study is to look for factors that affect lupus disease activity and potentially predict lupus flares through non-clinical tests
Conditions
Timeline
- Start date
- 2020-04-28
- Primary completion
- 2020-12-31
- Completion
- 2021-06-01
- First posted
- 2020-06-29
- Last updated
- 2020-06-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04449653. Inclusion in this directory is not an endorsement.